- Home
- BPOPM vs CERT Comparison
BPOPM vs CERT Comparison
Compare BPOPM & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPOPM
- CERT
- Stock Information
- Founded
- BPOPM N/A
- CERT 2008
- Country
- BPOPM United States
- CERT United States
- Employees
- BPOPM N/A
- CERT N/A
- Industry
- BPOPM Major Banks
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- BPOPM Finance
- CERT Technology
- Exchange
- BPOPM Nasdaq
- CERT Nasdaq
- Market Cap
- BPOPM N/A
- CERT 2.3B
- IPO Year
- BPOPM N/A
- CERT 2020
- Fundamental
- Price
- BPOPM $25.29
- CERT $11.01
- Analyst Decision
- BPOPM
- CERT Buy
- Analyst Count
- BPOPM 0
- CERT 6
- Target Price
- BPOPM N/A
- CERT $15.80
- AVG Volume (30 Days)
- BPOPM N/A
- CERT 1.4M
- Earning Date
- BPOPM N/A
- CERT 02-26-2025
- Dividend Yield
- BPOPM N/A
- CERT N/A
- EPS Growth
- BPOPM N/A
- CERT N/A
- EPS
- BPOPM N/A
- CERT N/A
- Revenue
- BPOPM N/A
- CERT $385,148,000.00
- Revenue This Year
- BPOPM N/A
- CERT $11.44
- Revenue Next Year
- BPOPM N/A
- CERT $8.90
- P/E Ratio
- BPOPM N/A
- CERT N/A
- Revenue Growth
- BPOPM N/A
- CERT 8.70
- 52 Week Low
- BPOPM N/A
- CERT $9.41
- 52 Week High
- BPOPM N/A
- CERT $19.29
- Technical
- Relative Strength Index (RSI)
- BPOPM 47.00
- CERT 28.81
- Support Level
- BPOPM $25.05
- CERT $10.79
- Resistance Level
- BPOPM $25.51
- CERT $12.27
- Average True Range (ATR)
- BPOPM 0.13
- CERT 0.63
- MACD
- BPOPM -0.00
- CERT -0.22
- Stochastic Oscillator
- BPOPM 52.17
- CERT 7.48
About BPOPM Popular Inc. Popular Capital Trust II - 6.125% Cumulative Monthly Income Trust Preferred Securities
Popular Capital Trust II is a statutory trust. It is engaged in issuing capital securities.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.